Browse by Poster Author

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Author

Type here to filter the list

A
Aarnio, Emma

School of Pharmacy, University of Eastern Finland, Kuopio
(171) Factors Associated with Reinitiation and Subsequent Discontinuation of Antiplatelet Medication in Patients with Peripheral Arterial Disease
Emma Aarnio
Favorite
Aarts, Janske

Pfizer Inc.
(035) Safety Events in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis Exposed to Tofacitinib (Xeljanz) or Biologics: Real-World Data from the CARRA Registry
Janske Aarts
Favorite
Abate, Andrea

University of Messina
(125) Low-Dose Aspirin and Risk of Anemia in Older Adults: Insights from a Danish Register-based Study
Andrea Abate
Favorite
Abbasi, Saad Hanif

University of Southern Denmark
(145) Acute cardiovascular adverse effects associated with the use of prescription medications: A Danish nationwide screening study
Saad Hanif Abbasi
Favorite
Abbey, Rachel

Office of the National Coordinator for Health Information Technology
(302) Prenatal syphilis in the US: characterizing screening and treatment during pregnancy in publicly and commercially insured individuals
Rachel Abbey
Favorite
Abdel Shaheed, Christina

2. Sydney Musculoskeletal Health, Faculty of Medicine and Health, The University of Sydney
(217) Patterns of opioid doses to compensated Australian workers with low back pain
Christina Abdel Shaheed
Favorite
Abdelgawwad, Khaled

Bayer AG
(202) Systematic Definition Development of Variables of Interest for Studies Using Administrative Databases
Khaled Abdelgawwad
Favorite
Abdullah, Sheikh

Western University
(349) Safety Analysis of Adverse Drug Reactions in United States: A 21-Year descriptive Study of FDA Adverse Event Reporting System
Sheikh Abdullah
Favorite
Abedian Kalkhoran, Hanieh

Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands
(055) Development and portability of a text mining algorithm for capturing disease progression in electronic health records of with stage IV non-small cell lung cancer treated with immuno-chemotherapy
Hanieh Abedian Kalkhoran
Favorite
Abellan, Alicia

RTI Health Solutions, Barcelona, Spain
(138) The risks of immune- and inflammatory related post-acute sequelae of COVID-19: a network study in 6 European countries, the US, and Korea
Alicia Abellan
Favorite
(219) Identification of migraine in electronic healthcare data sources: a headache for pharmacoepidemiologists – a systematic literature review
Alicia Abellan
Favorite
Abenhaim, Lucien

London School of Hygiene & Tropical Medicine
(195) Systematic emulation trials to evaluate the real-world effectiveness of multiple sclerosis treatments
Lucien Abenhaim
Favorite
Abente, Eugenio

CVS Health
(358) Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States
Eugenio Abente
Favorite
Abiodun, Abiola

National Pharmacovigilance Centre NAFDAC Abuja Nigeria
(366) Trends of COVID-19 Vaccine Adverse Event Following Immunization (AEFI): A One-year Retrospective Review Using the Passive Surveillance Data in the Nigerian National Database (Vigiflow).
Abiola Abiodun
Favorite
Abiodun, Aderonke

Institute of Cardiovascular Science, University College London, United Kingdom
(059) Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study
Aderonke Abiodun
Favorite
Aboulatta, Laila

University of Manitoba
(ASPOT42) Antiseizure Medications Use And the Risk Of Parkinson’s Disease: A 15-year Population-based Study
Laila Aboulatta
Favorite
Abtahi, Shahab

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
(015) Experts’ opinion on data quality assessments for multi-database pharmacoepidemiologic studies: A qualitative analysis
Shahab Abtahi
Favorite
(164) Early identification of the association between rofecoxib and cardiovascular adverse events using real-world data from the UK: A case-control study
Shahab Abtahi
Favorite
(CSPOT32) Impact of risk communication on thrombosis with thrombocytopenia syndrome for COVID-19 adenovirus vector vaccines on European healthcare professionals
Shahab Abtahi
Favorite
Abubakar, Asmau

National Pharmacovigilance Centre NAFDAC Abuja Nigeria
(366) Trends of COVID-19 Vaccine Adverse Event Following Immunization (AEFI): A One-year Retrospective Review Using the Passive Surveillance Data in the Nigerian National Database (Vigiflow).
Asmau Abubakar
Favorite
Abukadah, Halima

University of Kentucky
(197) Predicting CRC Screening Uptake using Machine Learning and Ensemble Models
Halima Abukadah
Favorite
Abunimeh, Hanan

Strathclyde institute of pharmacy and biomedical science University of Strathclyde, Glasgow
(144) A scoping Review of Factors Associated with the Prescribing of Direct Oral Anticoagulant Drugs (DOACs)
Hanan Abunimeh
Favorite
(251) The real-world use of medicines for the management of haematological malignancies in paediatric populations: an international scoping review.
Hanan Abunimeh
Favorite
Abu-Sheasha, Ghada

IQVIA
(002) A Quantitative Bias Analysis to Assess the Impact of Tumor Selection on Linear Growth in Observational Research: a Case Study in Renal Cancer.
Ghada Abu-Sheasha
Favorite
Abushukair, hassan

Jordan University of Science and Technology, Irbid, Jordan
(017) Immune Checkpoint Inhibitors and Overlap Syndrome of Myocarditis and Myositis or Myasthenia Gravis: Analysis of WHO VigiBase Database.
hassan Abushukair
Favorite
Aby, Elizabeth

Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA
(252) Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors vs dipeptidyl peptidase 4 inhibitors on liver outcomes in patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
Elizabeth Aby
Favorite
Acharya D, Leelavathi

Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
(082) Vitamin D and the Microvascular Complications of Type 2 Diabetes in India: A Case-Control Study
Leelavathi Acharya D
Favorite
Acharya, Ramya

Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India.
(045) Assessment of Readiness to Change in Individuals with Alcoholic Liver Disease: A Cross-Sectional Study in Indian Settings
Ramya Acharya
Favorite
Acharya, Raviraja V

Department of Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal
(045) Assessment of Readiness to Change in Individuals with Alcoholic Liver Disease: A Cross-Sectional Study in Indian Settings
Raviraja V Acharya
Favorite
(175) Implementation and Evaluation of Medication Therapy Management in Patients with Hypertension
Raviraja V Acharya
Favorite
Acheampong, Clement

University of North Carolina at Chapel Hill
(035) Assessing the utility of claims for haemoglobin A1c performance measures in characterizing glycemic control in older adult Medicare beneficiaries with diabetes.
Clement Acheampong
Favorite
(143) The prevalent new-user study design: a novel application to estimating the average treatment effect of statin discontinuation on mortality among traditional Medicare beneficiaries who discontinued statins
Clement Acheampong
Favorite
(BSPOT05) Interpreting Effect Estimates Across Racial and Ethnic Categories in Propensity Score-Based Analyses: An Application in US Medicare Beneficiaries Initiating Antidiabetic Medications
Clement Acheampong
Favorite
Acurcio, Francisco

Collaborating Centre for Technology Assessment in Health and Excellence (CCATES), Federal University of Minas Gerais, Belo Horizonte, Brazil
(001) Advancements in Rheumatoid Arthritis Management: An Analysis of Clinical Features and Treatment Outcomes in a Brazilian Cohort
Francisco Acurcio
Favorite
(023) Medication persistence in the treatment of rheumatoid arthritis in the Brazilian Public Health System
Francisco Acurcio
Favorite
(038) Treatment of rheumatoid arthritis in the Brazilian Public Health System: medication use profile
Francisco Acurcio
Favorite
Adaji, Enemona

Eli Lilly and Company
(004) Challenges of multi-country post-authorisation safety studies for surveillance of new medical products
Enemona Adaji
Favorite
(281) Progress Towards Enrollment in a US Pregnancy Registry for Galcanezumab and Lasmiditan
Enemona Adaji
Favorite
Adam, Atif

IQVIA
(174) Impact of Cardiovascular Medications on Non-Traumatic Amputation Rates in Type 2 Diabetes: Insights from a Large-Scale Retrospective Real-World Data Analysis
Atif Adam
Favorite
(259) Evaluating the Incidence and Burden of Gestational Diabetes in the United States: A Retrospective Study (2015-2022)
Atif Adam
Favorite
Adami, Hans-Olov

University of Oslo
(040) Trends in Management of Inflammatory Bowel Disease in Sweden and Norway, 1982-2016
Hans-Olov Adami
Favorite
Adams, Alyce

Stanford
(096) GLP1 comparative effectiveness against dementia onset in a large, multi-site cohort of type 2 diabetes patients: a trial emulation approach with targeted learning
Alyce Adams
Favorite
Adamson, Blythe

Flatiron Health
(012) Characterization of Novel Longitudinal Oncology Real World Datasets in Germany and UK
Blythe Adamson
Favorite
Addis, Antonio

Department of Epidemiology, ASL Roma1, SSR Lazio, Rome, Italy
(121) Mortality associated with use of etelcalcetide versus cinacalcet for the treatment of secondary hyperparathyroidism in patients in haemodialysis: a population based study in Lazio, Italy
Antonio Addis
Favorite
(307) Efficacy and safety of riluzole in the treatment of Amyotrophic Lateral Sclerosis, a population based study in Italy
Antonio Addis
Favorite
Addor, Marie-Claude

Department of Woman-Mother-Child, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
(275) Gabapentinoids exposure in early pregnancy and risk of congenital anomalies: an IMI ConcePTION European case-malformed control study
Marie-Claude Addor
Favorite
(308) Reproductive safety of glucagon-like peptide 1 receptor agonists (GLP1-RA) after maternal exposure in early pregnancy: a comparative ENTIS cohort study
Marie-Claude Addor
Favorite
(310) Risk of congenital ocular anomaly in EUROmediCAT: Assessment of the Potential Risk of Taking Medications during Pregnancy in Europe.
Marie-Claude Addor
Favorite
(313) Specific congenital anomalies associated with maternal Multiple Sclerosis: A ConcePTION European case-malformed control study
Marie-Claude Addor
Favorite
(318) The occurrence of specific congenital anomalies associated with maternal Systemic Lupus Erythematosus: A ConcePTION Case-malformed control study in EUROmediCAT
Marie-Claude Addor
Favorite
Adedapo, Aduragbenro

University of Ibadan
(290) The Effect of antibiotics prescription and length of hospitalization on mortality in patients with systemic infections
Aduragbenro Adedapo
Favorite
Adegboye, Michael

Brown University
(069) Denosumab Data Cleaning Algorithm to Inform Exposure Measurement and Study Inclusion: Results from Two International Databases
Michael Adegboye
Favorite
Adejumo, Ifedolapo

University of Lagos College of Medicine
(266) Identifying Potential Drug Interactions in Kidney-Impaired Individuals Co-infected with Human Immunodeficiency Virus and Malaria in Lagos: A Focus for Enhancing Treatment Strategies.
Ifedolapo Adejumo
Favorite
Adela, Ramu

NIPER Guwahati, Assam
(043) “Effect Of Pharmacological Interventions On Liver Function Parameters In Patients With NAFLD/NASH: A Systematic Review and Network meta-Analysis”
Ramu Adela
Favorite
(044) A Comprehensive Meta-Analysis Assessing the Diagnostic Accuracy of Non-invasive Markers to Discriminate NAFLD and NASH
Ramu Adela
Favorite
Adesuyan, Matthew

University College London and Guy's and St Thomas' Hospital London
(CSPOT51) Central vs. Non-central Angiotensin Converting Enzyme-inhibitors and the risk of Alzheimer's disease: A cohort study
Matthew Adesuyan
Favorite
Adeyeye, Christiana

NAFDAC Abuja Nigeria
(366) Trends of COVID-19 Vaccine Adverse Event Following Immunization (AEFI): A One-year Retrospective Review Using the Passive Surveillance Data in the Nigerian National Database (Vigiflow).
Christiana Adeyeye
Favorite
Adgent, Margaret

Department of Health Policy, Vanderbilt University Medical Center
(282) Opioid Analgesic and Antidepressant Use During Pregnancy and the Risk of Spontaneous Preterm Birth: A Nested Case-Control Study
Margaret Adgent
Favorite
Adil, Mohammad

Department of Pharmacology, SPER, Jamia Hamdard, New Delhi
(044) Dipeptidyl Peptidase-4 Inhibitors Use and Risk of Fracture in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Real-World Data
Mohammad Adil
Favorite
Adimadhyam, Sruthi

Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
(097) COVID-19 Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research
Sruthi Adimadhyam
Favorite
(141) Assessing Exposure to Recently Approved Medications to Inform Feasibility for Signal Identification Analyses in the FDA’s Sentinel System
Sruthi Adimadhyam
Favorite
(199) Analysis of New Molecular Entity Utilization Patterns using the Sentinel Distributed Database
Sruthi Adimadhyam
Favorite
(332) Background Rates of Neuroinflammatory Disorders and Atrial Fibrillation – Conditions of Interest for Vaccine Safety Studies
Sruthi Adimadhyam
Favorite
(BSPOT30) Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-marketing Uptake in the Sentinel Distributed Database
Sruthi Adimadhyam
Favorite
(CSPOT19) Tree-based mining of real-world data for potential safety signals associated with the use of dupilumab in the United States (2017-2023)
Sruthi Adimadhyam
Favorite
Adlam, David

Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Glenfield Hospital, Leicester, United Kingdom
(059) Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study
David Adlam
Favorite
Adomi, Motohiko

Harvard University
(272) Incidence of pregnancy among publicly and commercially insured childbearing-age women with warfarin treatment
Motohiko Adomi
Favorite
Afonso, Ana Sofia

Eli Lilly & Company
(136) A systematic review of algorithms used to identify neurodevelopmental disorders in electronic healthcare databases
Ana Sofia Afonso
Favorite
(233) Algorithms to identify major congenital malformations in routinely collected healthcare databases: A systematic literature review
Ana Sofia Afonso
Favorite
Afriyie, Daniel

Police Hospital
(181) Medication adherence and its association with blood pressure control at a teaching hospital in Ghana
Daniel Afriyie
Favorite
Agabiti, Nera

Department of Epidemiology, ASL Roma1, SSR Lazio, Rome, Italy
(121) Mortality associated with use of etelcalcetide versus cinacalcet for the treatment of secondary hyperparathyroidism in patients in haemodialysis: a population based study in Lazio, Italy
Nera Agabiti
Favorite
(307) Efficacy and safety of riluzole in the treatment of Amyotrophic Lateral Sclerosis, a population based study in Italy
Nera Agabiti
Favorite
Agan, Anna

Department of Population Medicine, Harvard Pilgrim Health Care Institute
(332) Background Rates of Neuroinflammatory Disorders and Atrial Fibrillation – Conditions of Interest for Vaccine Safety Studies
Anna Agan
Favorite
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Anna Agan
Favorite
agarwal, Nidhi

jamia hamdard, new delhi, india
(304) Brain derived Neurotrophic factor (BDNF): A potential biomarker for seizure associated cognitive impairment in adult persons with epilepsy (PWE)
Nidhi agarwal
Favorite
Aggarwal, Sulbh

University of Toronto
(069) Denosumab Data Cleaning Algorithm to Inform Exposure Measurement and Study Inclusion: Results from Two International Databases
Sulbh Aggarwal
Favorite
Agrawal, Utkarsh

Nuffield Department of Primary Care Health Sciences, University of Oxford
(336) Comparing disparities in uptake of COVID-19 and influenza vaccination among pregnant women, September 2020 and March 2022: English and Welsh national cohorts
Utkarsh Agrawal
Favorite
Aguado, Jaume

RTI Health Solutions
(344) Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Jaume Aguado
Favorite
Aguilar, Byron

Geriatric Research Education and Clinical Center Bedford VA Healthcare System
(094) Brain Imaging In United States Veterans Before and After Establishing Criteria for Use of Anti-amyloid Therapy for Treatment of Mild Cognitive Impairment and Alzheimer’s Dementia
Byron Aguilar
Favorite
Aguilera, Cristina

Clinical Pharmacology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain
(277) Maternal Mental Health in Focus: Real-World Data on Antidepressant Use. A Cohort Study in Catalonia.
Cristina Aguilera
Favorite
Agustí, Antonia

Clinical Pharmacology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain
(277) Maternal Mental Health in Focus: Real-World Data on Antidepressant Use. A Cohort Study in Catalonia.
Antonia Agustí
Favorite
Ahern, Thomas

Departments of Surgery of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT
(031) The relation between tamoxifen metabolism and time to discontinuation: A Bayesian pathway analysis in premenopausal breast cancer patients
Thomas Ahern
Favorite
Ahmadi, Fatemeh

Westsern University
(115) A Critical Methodological Appraisal of Studies Assessing Computerized Clinical Decision Support Systems (CDSS) Success in Improving Prescription Safety in Patients with Low Levels of Kidney Function
Fatemeh Ahmadi
Favorite
(286) Safety of the Use of Fluoroquinolone Antibiotics in Patients with Kidney Disease
Fatemeh Ahmadi
Favorite
(349) Safety Analysis of Adverse Drug Reactions in United States: A 21-Year descriptive Study of FDA Adverse Event Reporting System
Fatemeh Ahmadi
Favorite
(ASPOT45) Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease
Fatemeh Ahmadi
Favorite
Ahmadizar, Fariba

Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
(288) Patterns of Prescribed and Dispensed Medicines among Non-Hospitalized Pregnant women with COVID-19: a Prospective Meta-analysis pooling findings from Healthcare Databases in Europe and North America
Fariba Ahmadizar
Favorite
(328) A Comprehensive Review and Meta-analysis of COVID-19 Vaccine Studies in Vulnerable Populations- Analysis of 126 observational and clinical trials up to November 2022
Fariba Ahmadizar
Favorite
(345) Mapping Genetic and Molecular Contributions to Vaccine Adverse Reactions: a systematic review of observational studies
Fariba Ahmadizar
Favorite
(349) Patient-level prognostic models for COVID-19 vaccine effectiveness and safety: a systematic review
Fariba Ahmadizar
Favorite
(359) Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European Healthcare Data Sources: Methods and Results of the Second Study Feasibility Assessment
Fariba Ahmadizar
Favorite
Ahmad, Tufail

Department of Pharmacology, SPER, Jamia Hamdard, New Delhi
(044) Dipeptidyl Peptidase-4 Inhibitors Use and Risk of Fracture in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Real-World Data
Tufail Ahmad
Favorite
Ahmed, Ali

Riphah International University Islamabad, Pakistan
(290) Impact of Community Pharmacist-Led Services in the Global Fight Against HIV/AIDS: A Systematic Review
Ali Ahmed
Favorite
Ahmed, Haroon

School of Medicine, Cardiff University
(295) Use of antibacterials and suspected acute renal failure in Brazil: pharmacovigilance analysis, 2018-2023
Haroon Ahmed
Favorite
Ahmed, Iftekhar

Purdue University
(193) Medication Data in Research: Improving Completeness Using Rule-based Algorithms on Textual Variables
Iftekhar Ahmed
Favorite
Ahmed, Ismaïl

Inserm
(252) Covid19 Vaccination During Pregnancy: a Descriptive Study of Uptake and Safety for Mothers and Infants Using the Nationwide French National Health System
Ismaïl Ahmed
Favorite
Ahmed, Wouter

PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
(190) Do efficacy results obtained from randomised controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
Wouter Ahmed
Favorite
Ailes, Elizabeth

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
(244) Associations between diphenhydramine and specific birth defects stratified by imputed indication, National Birth Defects Prevention Study and Birth Defects Study to Evaluate Pregnancy exposureS
Elizabeth Ailes
Favorite
(270) Concomitant Periconceptional Opioid Medication, Alcohol, and Tobacco Use
Elizabeth Ailes
Favorite
Air, Tracy

Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
(111) Prevalence of Polypharmacy, Multimorbidity and Association with Mortality in Older Aboriginal and Torres Strait Islander People.
Tracy Air
Favorite
(119) Glucose lowering medication utilization before and after entry into long-term care among older people with diabetes
Tracy Air
Favorite
(127) National trends in utilization of glucose lowering medications by older people with diabetes in long-term care facilities, 2009 to 2019
Tracy Air
Favorite
Ajao, Adebola

Center for Drug Evaluation and Research, Food and Drug Administration
(233) Algorithms to identify major congenital malformations in routinely collected healthcare databases: A systematic literature review
Adebola Ajao
Favorite
(234) Analysis of Medicinal Product Utilization Data in the FDA Sentinel System to Inform the Development of a Pregnancy Safety Study Framework
Adebola Ajao
Favorite
(235) Analysis of Postapproval Pregnancy Safety Studies Associated with FDA Approved Products
Adebola Ajao
Favorite
(312) Sources and Characteristics of Quantitative Human Pregnancy Safety Data in U.S. FDA Approved Product Labeling, 2015-2021
Adebola Ajao
Favorite
Akbari, Ashley

Population Data Science, Swansea University Medical School, Swansea University
(336) Comparing disparities in uptake of COVID-19 and influenza vaccination among pregnant women, September 2020 and March 2022: English and Welsh national cohorts
Ashley Akbari
Favorite
Akhtar, Sandia

Acumen LLC
(127) Risk factors for severe outcomes among patients hospitalized with COVID-19 in US Medicare between December 2020 and March 2023
Sandia Akhtar
Favorite
(222) Medically-attended cannabis-related disorders among U.S. Medicare beneficiaries, 2017–2022
Sandia Akhtar
Favorite
Akici, Ahmet

Department of Medical Pharmacology, School of Medicine, Marmara University
(045) Effect of COVID-19 restrictions on insulin consumption in Turkey: Results from Changes in Nationwide Drug Consumption During the Pandemic Study
Ahmet Akici
Favorite
(113) Investigation of the Consumption Trend of Inhalants Used in the Treatment of Obstructive Airway Diseases During the COVID-19 Pandemic
Ahmet Akici
Favorite
(269) Comparison of antidepressant use in normal-age and late-age pregnancies
Ahmet Akici
Favorite
Akinola, Pelumi

University of Manitoba
(301) Prenatal Exposure to Gabapentin and the Risk of Autism Spectrum Disorder in Children
Pelumi Akinola
Favorite
Akunne, Onyinye

UNIVERSITY OF THE WESTERN CAPE
(290) The Effect of antibiotics prescription and length of hospitalization on mortality in patients with systemic infections
Onyinye Akunne
Favorite
Al Dali, Hammad

Pharmacovigilance Executive Directorate, Saudi Food and Drug Authority.
(010) Comprehensive Analysis of Pharmacovigilance Inspections Practices: Focus on QPPV Responsibilities in the Pharmaceutical Industry in Saudi Arabia
Hammad Al Dali
Favorite
Al Yami, Majed

Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Majed Al Yami
Favorite
Alaboud, Mashael

Pharmaceutical Care Department, King Abdulaziz Medical City
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Mashael Alaboud
Favorite
Alakeel, Abdulaziz

Drug Sector, Saudi Food and Drug Authority
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Abdulaziz Alakeel
Favorite
(350) Transverse Myelitis Associated with Tozinameran Use: Adverse Events- Signal
Abdulaziz Alakeel
Favorite
Alamer, Ahmad

Prince Sattam Bin Abdulaziz University
(027) Prescribing Patterns of Biological Therapies in Psoriasis Management: A Retrospective Cohort Study in Saudi Arabia
Ahmad Alamer
Favorite
Alamri, Roaa

Saudi Food and Drug Authority
(350) Transverse Myelitis Associated with Tozinameran Use: Adverse Events- Signal
Roaa Alamri
Favorite
Alam, Sarah

Department of Population Medicine, Harvard Pilgrim Health Care Institute
(230) Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table
Sarah Alam
Favorite
Albano, Jessica

Syneos Health
(270) Impacts of Dobbs Decision and COVID-19 on Abortion-related Trends within TriNetX Electronic Medical Record Data
Jessica Albano
Favorite
(359) Vaccination Use among Pregnant Women 2016-2023: An Analysis Using Healthcare Claims
Jessica Albano
Favorite
Albogami, Yasser

College of Pharmacy, King Saud University
(076) Treatment Modification Patterns of Glucose-Lowering Agents in Saudi Arabia: A Retrospective Real-world Data Analysis
Yasser Albogami
Favorite
(103) Weight Loss Medication Prescribing Patterns: Real-World Data Analysis from 2015 to 2023
Yasser Albogami
Favorite
Albrecht, Jennifer

University of Maryland
(079) Medication Use Patterns Among Older Adults With Obstructive Sleep Apnea With and Without Comorbid Insomnia
Jennifer Albrecht
Favorite
Alcalde Herraiz, Marta

University of Oxford
(102) Drug target Mendelian Randomisation vs regression methods: estimating causal effects of sclerostin inhibition on bone mineral density and fracture risk
Marta Alcalde Herraiz
Favorite
Alcusky, Matthew

UMass Chan Medical School
(105) Effectiveness of Mono and Dual Antidementia Pharmacotherapy Among US Nursing Home Residents
Matthew Alcusky
Favorite
Aldemikhi, Reem

College of Pharmacy, King Saud University
(103) Weight Loss Medication Prescribing Patterns: Real-World Data Analysis from 2015 to 2023
Reem Aldemikhi
Favorite
Alderden, Jenny

Boise State University
(205) There's something about Albumin: Applying the Roadmap for Causal Inference to Estimate the Effect of Albumin Levels on Pressure Injury Development in Hospital Settings
Jenny Alderden
Favorite
Aldosari, Saad

Prince Sattam Bin Abdulaziz University
(027) Prescribing Patterns of Biological Therapies in Psoriasis Management: A Retrospective Cohort Study in Saudi Arabia
Saad Aldosari
Favorite
Aleid, Haya

Ministry of Health, Riyadh, Saudi Arabia
(016) Empirical Estimation of Hepatocellular Carcinoma Prevalence in Saudi Arabia: A Gender and Age Group Analysis
Haya Aleid
Favorite
Alemu, Asnakech

Ethiopian Food and Drug Authority
(331) Applicability of Selected Brighton Collaboration Case Definitions in Prospective Hospital-Based Safety Surveillance for Covid-19 Vaccines, Addis Ababa, Ethiopia
Asnakech Alemu
Favorite
Alessi, Anu

Safety Epidemiology, Chief Medical Office, R&D, AstraZeneca, Cambridge, UK
(340) Epidemiology of Thrombotic Thrombocytopenia Syndrome before, during and post COVID-19 pandemic: English sentinel network cohort studies
Anu Alessi
Favorite
Alessi-Severini, Silvia

University of Manitoba
(263) Antiseizure medication use during pregnancy and the Risk of adverse neonatal birth outcomes in two Canadian provinces
Silvia Alessi-Severini
Favorite
(274) Gabapentin Use During Pregnancy and the Risk of Adverse Neonatal Birth Outcomes in two Canadian provinces
Silvia Alessi-Severini
Favorite
(301) Prenatal Exposure to Gabapentin and the Risk of Autism Spectrum Disorder in Children
Silvia Alessi-Severini
Favorite
Alexander, G. Caleb

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
(090) Characteristics of Registered Clinical Trials Investigating Therapeutic Interventions for Long COVID
G. Caleb Alexander
Favorite
(097) Cost-Effectiveness of Lecanemab (Leqembi) for Individuals With Early-Stage Alzheimer’s Disease
G. Caleb Alexander
Favorite
(105) Hospital-level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort Study
G. Caleb Alexander
Favorite
(114) New Medication Use in Post-Acute Sequelae Of COVID-19 (PASC): An EHR-based Study From the RECOVER Program
G. Caleb Alexander
Favorite
(116) Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe Covid-19: An Analysis of the National Covid Cohort Collaborative (N3C)
G. Caleb Alexander
Favorite
(133) The Comparative Effectiveness of Baricitinib And Tocilizumab in Hospitalized Patients With Covid: A Retrospective Cohort Study of The National Covid Cohort Collaborative (N3C)
G. Caleb Alexander
Favorite
(150) Effect of Race on Classification of Atherosclerotic Risk Using A National Cardiovascular Risk Prediction Tool
G. Caleb Alexander
Favorite
(186) Who Should Be Prioritised For Primary Care Medication Review? Consensus Validation And Point Prevalence of Explicit Prescribing Indicators
G. Caleb Alexander
Favorite
(301) Anxiety Disorders Diagnosed in Outpatient Encounters Among Commercially Insured US Adults
G. Caleb Alexander
Favorite
(ASPOT25) Drug-Drug Interactions Between Direct-Acting Oral Anticoagulants and Antiseizure Medications: A Target Trial Emulation
G. Caleb Alexander
Favorite
(ASPOT26) Effect of drug-drug interactions involving direct-acting oral anticoagulants and statins on the risk of bleeding
G. Caleb Alexander
Favorite
Alexander, Myriam

Safety Epidemiologyy, Chief Medical Office, R&D, Astrazeneca, Luton, UK
(258) Enhanced pharmacovigilance reporting using PRIM: conditions to make it an alternative to traditional pregnancy registry
Myriam Alexander
Favorite
Alexander, Tyler

SimulStat Incorporated
(161) Linking clinical trial participants to their U.S. real-world data through tokenization: a practical guide
Tyler Alexander
Favorite
Alexandrou, Ari

Roche
(012) Ensuring Safety: A Comprehensive Review of the Subcutaneous Administration of Biologics
Ari Alexandrou
Favorite
Al-Fadel, Nouf

Drug Safety and Risk Management department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
(025) Improving the Quality of Drug Safety Review Reports: SFDA Experience
Nouf Al-Fadel
Favorite
(030) Pharmacogenomics-Pharmacovigilance Project: SFDA Experience
Nouf Al-Fadel
Favorite
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Nouf Al-Fadel
Favorite
(304) Prevalence of medication use for COVID-19 treatment in pregnancy: a two-stage individual patient data meta-analysis combining international registries.
Nouf Al-Fadel
Favorite
(316) Potential Association of Syndrome of Inappropriate Antidiuretic Hormone Secretion with Olanzapine Use
Nouf Al-Fadel
Favorite
(CSPOT45) Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase
Nouf Al-Fadel
Favorite
Alfakhri, Almaha

Saudi Food and Drug Authority
(076) Treatment Modification Patterns of Glucose-Lowering Agents in Saudi Arabia: A Retrospective Real-world Data Analysis
Almaha Alfakhri
Favorite
(177) Indapamide-Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records
Almaha Alfakhri
Favorite
(197) The Risk of Hypokalemia in Patients Treated with Levetiracetam: A Comparative Cohort Study
Almaha Alfakhri
Favorite
Alghamdi, Ali

Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology & -Economics, University of Groningen, 9713 AV Groningen, The Netherlands
(083) A Case-control Study On Polypharmacy And Co-medications in Alzheimer’s Disease
Ali Alghamdi
Favorite
Alghamdi, Eman

Drug Safety and Risk Management department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
(017) Immune Checkpoint Inhibitors and Overlap Syndrome of Myocarditis and Myositis or Myasthenia Gravis: Analysis of WHO VigiBase Database.
Eman Alghamdi
Favorite
(233) Algorithms to identify major congenital malformations in routinely collected healthcare databases: A systematic literature review
Eman Alghamdi
Favorite
Alghamdi, Maha

Drug Safety and Risk Management department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
(030) Pharmacogenomics-Pharmacovigilance Project: SFDA Experience
Maha Alghamdi
Favorite
Alghamdi, Waad

Saudi Food and Drug Authority
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Waad Alghamdi
Favorite
Alhamed, Meshal

College of Medicine, King Saud University
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Meshal Alhamed
Favorite
Alharbi, Aisha

Pharmaceutical Care Department, King Abdulaziz Medical City
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Aisha Alharbi
Favorite
Alharbi, Fawaz

Drug Safety and Risk Management department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
(017) Immune Checkpoint Inhibitors and Overlap Syndrome of Myocarditis and Myositis or Myasthenia Gravis: Analysis of WHO VigiBase Database.
Fawaz Alharbi
Favorite
(025) Improving the Quality of Drug Safety Review Reports: SFDA Experience
Fawaz Alharbi
Favorite
(030) Pharmacogenomics-Pharmacovigilance Project: SFDA Experience
Fawaz Alharbi
Favorite
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Fawaz Alharbi
Favorite
(316) Potential Association of Syndrome of Inappropriate Antidiuretic Hormone Secretion with Olanzapine Use
Fawaz Alharbi
Favorite
(CSPOT45) Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase
Fawaz Alharbi
Favorite
Alhathlol, Ghaida

Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Ghaida Alhathlol
Favorite
Alhawas, Solaiman

Saudi Food & Drug Authority (SFDA)
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Solaiman Alhawas
Favorite
(316) Potential Association of Syndrome of Inappropriate Antidiuretic Hormone Secretion with Olanzapine Use
Solaiman Alhawas
Favorite
(CSPOT45) Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase
Solaiman Alhawas
Favorite
Alhusayni, Lama

SFDA
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Lama Alhusayni
Favorite
Ali, Ayad

Aetion, Inc
(091) Characterization of select laboratory test in administrative healthcare data and data from commercial laboratories among patients with COVID-19 diagnosed in outpatient settings
Ayad Ali
Favorite
Alibone, Marco

InGef – Institute for Applied Health Research Berlin GmbH
(308) Prevalence, Comorbidities, and Healthcare Costs of Rare Genetic Diseases in Germany: A Claims Database Study
Marco Alibone
Favorite
Alix, Caroline

Brigham and Women's Hospital
(151) Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real-World Data: A Validation Study from the INVESTED-Medicare Linkage
Caroline Alix
Favorite
Aljohani, Hadir

Drug Safety and Risk Management department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
(030) Pharmacogenomics-Pharmacovigilance Project: SFDA Experience
Hadir Aljohani
Favorite
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Hadir Aljohani
Favorite
Aljohani, Sarah

Department of Clinical Pharmacy, King Fahad Armed Forces Hospital
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Sarah Aljohani
Favorite
Alkhlaifat, Rahaf

Strathclyde institute of pharmacy and biomedical science University of Strathclyde, Glasgow
(144) A scoping Review of Factors Associated with the Prescribing of Direct Oral Anticoagulant Drugs (DOACs)
Rahaf Alkhlaifat
Favorite
(251) The real-world use of medicines for the management of haematological malignancies in paediatric populations: an international scoping review.
Rahaf Alkhlaifat
Favorite
Allegaert, Karel

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium
(315) The BELpREG Registry on Perinatal Medication Exposure and Mother-Infant Outcomes: Preliminary Insights into this unique Pregnancy Cohort in Belgium
Karel Allegaert
Favorite
Allen, Kristen

Pfizer Inc.
(099) Distinguishing Hospital Encounters as "with" vs "for" COVID-19 Using A Large US Administrative Claims Database
Kristen Allen
Favorite
Allen, Treasure

OCHIN
(114) New Medication Use in Post-Acute Sequelae Of COVID-19 (PASC): An EHR-based Study From the RECOVER Program
Treasure Allen
Favorite
Allignol, Arthur

Daiichi Sankyo Europe GmbH
(036) The ICH E9(R1) Estimand Framework in the Context of Real-World Data and Observational Studies
Arthur Allignol
Favorite
Allin, Kristine H.

Aalborg University
(052) Drug Repurposing in Crohn’s Disease using Danish real-world data
Kristine H. Allin
Favorite
Allotta, Alessandra

Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy
(120) How much frequently are biological drugs used in patients over 65 years with immune-mediated inflammatory diseases through the Italian VALORE distributed database network
Alessandra Allotta
Favorite
Almadani, Ohoud

Saudi Food and Drug Authority
(076) Treatment Modification Patterns of Glucose-Lowering Agents in Saudi Arabia: A Retrospective Real-world Data Analysis
Ohoud Almadani
Favorite
(177) Indapamide-Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records
Ohoud Almadani
Favorite
(197) The Risk of Hypokalemia in Patients Treated with Levetiracetam: A Comparative Cohort Study
Ohoud Almadani
Favorite
Almarsdóttir, Anna Birna

University of Copenhagen
(CSPOT32) Impact of risk communication on thrombosis with thrombocytopenia syndrome for COVID-19 adenovirus vector vaccines on European healthcare professionals
Anna Birna Almarsdóttir
Favorite
Almas, Mariana

IQVIA
(CSPOT30) Identifying regulatory outcomes of Multi-Database and non- Multi-Database non-interventional Post Authorisation Safety Studies using publicly available information
Mariana Almas
Favorite
Almeida, Diogo

University of Lisbon
(027) More-EUROPA (More Effectively Using Registries) – A cross-sectional survey assessing evidence needs around the introduction of new medicines
Diogo Almeida
Favorite
(096) COVID-19 Pandemic and the Consumption of Self-Care Products for Pediculosis Capitis in Portugal: An Interrupted Time-Series Analysis
Diogo Almeida
Favorite
(CSPOT27) A Comparative Analysis of Imposed Post-Authorization Measures for Advanced Therapy Medicinal Products Approved Between 2009-2013 in Europe and in United States of America
Diogo Almeida
Favorite
AlMeshari, Sara

SFDA
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Sara AlMeshari
Favorite
Almohammed, Omar

Department of Clinical Pharmacy, College of Pharmacy, King Saud University
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Omar Almohammed
Favorite
Almohareb, Sumaya

King Saud bin Abdulaziz University for Health Science
(197) The Risk of Hypokalemia in Patients Treated with Levetiracetam: A Comparative Cohort Study
Sumaya Almohareb
Favorite
Almomen, Salwa

Saudi Food and Drug Authority (SFDA)
(010) Comprehensive Analysis of Pharmacovigilance Inspections Practices: Focus on QPPV Responsibilities in the Pharmaceutical Industry in Saudi Arabia
Salwa Almomen
Favorite
Almossawi, Ofran

Great Ormond Street Hospital for Children NHS Foundation Trust
(297) Use of systemic fluoroquinolones in primary care and hospital settings in the UK: A population-level cohort study
Ofran Almossawi
Favorite
Almqvist, Catarina

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
(BSPOT24) Data Mining for Adverse Events of Montelukast in Children and Adolescents: A Tree-Based Scan Statistics Analysis of Swedish Nationwide Data
Catarina Almqvist
Favorite
Almutairi, Abdulaale

Saudi Food and Drug Authority
(304) Prevalence of medication use for COVID-19 treatment in pregnancy: a two-stage individual patient data meta-analysis combining international registries.
Abdulaale Almutairi
Favorite
Almutairi, Abdulaali

Drug Sector, Saudi Food and Drug Authority
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Abdulaali Almutairi
Favorite
Almutairi, Malak

Executive department of research and studies ,Saudi Food and Drug Authority, Riyadh, Saudi Arabia
(010) Comprehensive Analysis of Pharmacovigilance Inspections Practices: Focus on QPPV Responsibilities in the Pharmaceutical Industry in Saudi Arabia
Malak Almutairi
Favorite
Alnajem, Afnan

Department of Biostatistics, Epidemiology and scientific computing, King Faisal Specialist Hospital and research Center- Riyadh
(016) Empirical Estimation of Hepatocellular Carcinoma Prevalence in Saudi Arabia: A Gender and Age Group Analysis
Afnan Alnajem
Favorite
AlNasser, Shahad

Saudi Food and Drug Authority
(025) Improving the Quality of Drug Safety Review Reports: SFDA Experience
Shahad AlNasser
Favorite
(030) Pharmacogenomics-Pharmacovigilance Project: SFDA Experience
Shahad AlNasser
Favorite
(316) Potential Association of Syndrome of Inappropriate Antidiuretic Hormone Secretion with Olanzapine Use
Shahad AlNasser
Favorite
Alomar, Mukhtar

Pharmaceutical Care Services, Eastern Health Cluster
(027) Prescribing Patterns of Biological Therapies in Psoriasis Management: A Retrospective Cohort Study in Saudi Arabia
Mukhtar Alomar
Favorite
Alorf, Nora

Saudi Food & Drug Authority
(025) Improving the Quality of Drug Safety Review Reports: SFDA Experience
Nora Alorf
Favorite
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Nora Alorf
Favorite
(CSPOT45) Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase
Nora Alorf
Favorite
AlOtaibi, Abdullatif

Pharmacovigilance Executive Directorate (Pharmacovigilance Inspection Section), Saudi Food and Drug Authority, Riyadh, Saudi Arabia
(010) Comprehensive Analysis of Pharmacovigilance Inspections Practices: Focus on QPPV Responsibilities in the Pharmaceutical Industry in Saudi Arabia
Abdullatif AlOtaibi
Favorite
Alowayesh, Maryam

School of Pharmacy, Kuwait University
(198) Utilisation Patterns and Trends of Statins in Kuwait from 2012 to 2022: A Population-Based Study
Maryam Alowayesh
Favorite
Alqahtani, Saleh

Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia, Division of Gastroenterology & Hepatology, Johns Hopkins University, Baltimore, MD, USA
(016) Empirical Estimation of Hepatocellular Carcinoma Prevalence in Saudi Arabia: A Gender and Age Group Analysis
Saleh Alqahtani
Favorite
Alrasheed, Meshael

Saudi Food & Drug Authority (SFDA)
(CSPOT45) Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase
Meshael Alrasheed
Favorite
Alroba, Raseel

Saudi Food and Drug Authority
(177) Indapamide-Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records
Raseel Alroba
Favorite
(197) The Risk of Hypokalemia in Patients Treated with Levetiracetam: A Comparative Cohort Study
Raseel Alroba
Favorite
Alrohaimi, Manal

Drug Safety and Risk Management department, Executive Directorate of Pharmacovigilance, Drug Sector, Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
(030) Pharmacogenomics-Pharmacovigilance Project: SFDA Experience
Manal Alrohaimi
Favorite
Alrubaish, Fares

Saudi Food and Drug Authority
(025) Improving the Quality of Drug Safety Review Reports: SFDA Experience
Fares Alrubaish
Favorite
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Fares Alrubaish
Favorite
Alrwisan, Adel

SAUDI FOOD AND DRUG AUTHORITY
(076) Treatment Modification Patterns of Glucose-Lowering Agents in Saudi Arabia: A Retrospective Real-world Data Analysis
Adel Alrwisan
Favorite
(177) Indapamide-Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health Records
Adel Alrwisan
Favorite
(197) The Risk of Hypokalemia in Patients Treated with Levetiracetam: A Comparative Cohort Study
Adel Alrwisan
Favorite
Alsaffar, Noor

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde
(198) Utilisation Patterns and Trends of Statins in Kuwait from 2012 to 2022: A Population-Based Study
Noor Alsaffar
Favorite
Alshahrani, Walaa

Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Walaa Alshahrani
Favorite
Alshatti, Fahad

Strathclyde Institute of Pharmacy and Biomedical Science (SIPBS), University of Strathclyde, Glasgow
(229) A national point prevalence survey to assess surgical antibiotic prophylaxis duration and timing in obstetrics and gynaecological surgery in Kuwait
Fahad Alshatti
Favorite
(237) Assessment of Surgical Antibiotic Prophylaxis Appropriateness in Obstetrics and Gynaecological Surgery in Kuwait: A National Point Prevalence Survey
Fahad Alshatti
Favorite
(270) Knowledge Attitude and Practice of Obstetricians and Gynaecologists towards appropriate surgical antibiotic prophylaxis prescribing in Obstetric and gynaecological surgery in Kuwait: A national cross-sectional survey
Fahad Alshatti
Favorite
(281) Prevalence and Patterns of Antibiotic Prophylaxis in Kuwaiti Obstetric and Gynaecological Surgery: A National Point Prevalence Survey
Fahad Alshatti
Favorite
Alsheikh, Fatimah

Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Fatimah Alsheikh
Favorite
Alsina, Ema

Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
(288) Patterns of Prescribed and Dispensed Medicines among Non-Hospitalized Pregnant women with COVID-19: a Prospective Meta-analysis pooling findings from Healthcare Databases in Europe and North America
Ema Alsina
Favorite
Alsugeir, Dana

University college london
(220) Common Mental Health Diagnoses Arising from or Coinciding with Menopausal Transition and Prescribing of SSRIs/SNRIs and Other Psychotropic Medications
Dana Alsugeir
Favorite
Althobaiti, Hussam

Hussam Althobaiti
(236) Assessing Antibiotic Prescribing Patterns in Private Outpatient Settings: A WHO AWaRe Classification Analysis in a Jeddah Polyclinic
Hussam Althobaiti
Favorite
Althoff, Amanda

OMNY Health
(044) Utilizing Real-World Data to Create an External Control Arm for a Phase 3 Trial of Deucravacitinib for Treatment of Plaque Psoriasis
Amanda Althoff
Favorite
(045) Vitiligo Disease Severity and Real-World Treatment Patterns
Amanda Althoff
Favorite
(089) Characteristics of Glucagon-Like Peptide-1 Agonist Prescriptions for Weight Loss in the Real-World Setting
Amanda Althoff
Favorite
Althunian, Turki

Saudi Food and Drug Authority
(076) Treatment Modification Patterns of Glucose-Lowering Agents in Saudi Arabia: A Retrospective Real-world Data Analysis
Turki Althunian
Favorite
(197) The Risk of Hypokalemia in Patients Treated with Levetiracetam: A Comparative Cohort Study
Turki Althunian
Favorite
Altomare, Ivy

Flatiron Health
(360) Feasibility of Prospective Real-World Studies to Fulfill Regulatory Commitments and Requirements in Oncology within the United States (US)
Ivy Altomare
Favorite
Alvares-Teodoro, Juliana

Universidade Federal de Minas Gerais / Collaborating Centre for Technology Assessment in Health and Excellence (CCATES), Federal University of Minas Gerais, Belo Horizonte, Brazil
(001) Advancements in Rheumatoid Arthritis Management: An Analysis of Clinical Features and Treatment Outcomes in a Brazilian Cohort
Juliana Alvares-Teodoro
Favorite
(023) Medication persistence in the treatment of rheumatoid arthritis in the Brazilian Public Health System
Juliana Alvares-Teodoro
Favorite
(038) Treatment of rheumatoid arthritis in the Brazilian Public Health System: medication use profile
Juliana Alvares-Teodoro
Favorite
Alvir, Jose

Pfizer
(303) Estimation of period-based costs associated with individual chronic complications of rare inherited diseases, in the context of multimorbidity, using real-world data.
Jose Alvir
Favorite
Alwafae, Sana

Sana Alwafai, pharmD
(236) Assessing Antibiotic Prescribing Patterns in Private Outpatient Settings: A WHO AWaRe Classification Analysis in a Jeddah Polyclinic
Sana Alwafae
Favorite
Alyazidi, Wejdan

Pharmaceutical Care Services, Eastern Health Cluster
(027) Prescribing Patterns of Biological Therapies in Psoriasis Management: A Retrospective Cohort Study in Saudi Arabia
Wejdan Alyazidi
Favorite
Alyea, Jennifer

Eli Lilly and Company
(084) A Cohort Study to Evaluate the Real-World Utilization and Effectiveness of Bebtelovimab Compared to Nirmatrelvir/Ritonavir among Patients with Mild-to-Moderate COVID-19 Who Are at High Risk for Progressing to Severe Illness
Jennifer Alyea
Favorite
(086) Assessing the Robustness of Comparative Effectiveness Studies: An Applied Example Evaluating the Effectiveness of Bebtelovimab In COVID-19
Jennifer Alyea
Favorite
Ama Nkansah, Florence

Korle Bu Teaching Hospital
(181) Medication adherence and its association with blood pressure control at a teaching hospital in Ghana
Florence Ama Nkansah
Favorite
Amalia, Lia

School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Institut Teknologi Bandung (ITB), Bandung, Indonesia
(291) Interest in Use of a Mobile App for Reporting Adverse Drug Reactions: A Survey Study Among Healthcare Professionals and the Public in Indonesia
Lia Amalia
Favorite
Amankwa Harrison, Mark

Korle Bu Teaching Hospital
(181) Medication adherence and its association with blood pressure control at a teaching hospital in Ghana
Mark Amankwa Harrison
Favorite
Ambasta, Anshula

University of British Columbia
(230) A pragmatic randomized trial assessing the impact of peer comparison and therapeutic recommendations on antibiotic prescribing patterns of family physicians for uncomplicated lower urinary tract infections
Anshula Ambasta
Favorite
Ambati, Srikanth

Regeneron Pharmaceuticals, Inc
(065) Incidence of any Infections and SARS-COV-2 infections in Patients Receiving Treatment for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Real-World Evidence from a Large US National Claims Database
Srikanth Ambati
Favorite
Ambrosini, Anna

Fondazione Telethon
(317) Use of European rare disease registries to describe the natural history and disease progression of Spinal Muscular Atrophy (SMA) over time
Anna Ambrosini
Favorite
Ameeriar, Yasmeen

University of Toronto
(323) Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: a scoping review
Yasmeen Ameeriar
Favorite
Amend, Kandace

Optum Epidemiology
(275) Linkage of Mother and Infant Records using Commercial Claims Data within the Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative
Kandace Amend
Favorite
(335) Claims Profile Review to Assess Age at Vaccination Among Young Males Who Appeared to Receive the 4-valent Human Papillomavirus (HPV) Vaccine (4vHPV vaccine) in the United States
Kandace Amend
Favorite
(352) Safety of Ancestral Monovalent BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax) COVID-19 Vaccines in US Children Aged 6 months to 17 years
Kandace Amend
Favorite
(358) Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States
Kandace Amend
Favorite
Amin, Alpesh

University of California Irvine
(103) Evaluation of Two Methods in Minimizing Confounding by Indication Bias in Observational Research: an Example Based on Guideline-recommended COVID-19 therapies
Alpesh Amin
Favorite
Amiri, Leila

University of British Columbia, Vancouver, BC, Canada
(104) Healthcare Utilization Among People Living With Long COVID 2.5 Years After Acute COVID-19
Leila Amiri
Favorite
Amiri, Malek

Université Laval
(219) What motivates patients with chronic musculoskeletal pain to use medical cannabis as a treatment strategy? Results from a questionnaire study.
Malek Amiri
Favorite
Amit, Mati

Biosense Webster
(ASPOT11) Evaluation of ablation workflow for Paroxysmal and Persistent Atrial Fibrillation Treatment using electronic health record linked with digital health data
Mati Amit
Favorite
Amjad, Halima

Johns Hopkins University
(079) Medication Use Patterns Among Older Adults With Obstructive Sleep Apnea With and Without Comorbid Insomnia
Halima Amjad
Favorite
Amos, Yariv

Biosense Webster
(ASPOT11) Evaluation of ablation workflow for Paroxysmal and Persistent Atrial Fibrillation Treatment using electronic health record linked with digital health data
Yariv Amos
Favorite
Amzal, Billy

RE-MEDs
(195) Systematic emulation trials to evaluate the real-world effectiveness of multiple sclerosis treatments
Billy Amzal
Favorite
Anand, Amal

Reserch Assistant
(184) Validity of Inpatient ICD 10 Codes for Heat-related Illnesses in US Medicare Data
Amal Anand
Favorite
Anand, Priyanka

Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital
(043) Utilization of newly approved targeted immunomodulating treatments for atopic dermatitis
Priyanka Anand
Favorite
(272) Incidence of pregnancy among publicly and commercially insured childbearing-age women with warfarin treatment
Priyanka Anand
Favorite
Anand, Sneha N

University of Oxford
(336) Comparing disparities in uptake of COVID-19 and influenza vaccination among pregnant women, September 2020 and March 2022: English and Welsh national cohorts
Sneha N Anand
Favorite
(340) Epidemiology of Thrombotic Thrombocytopenia Syndrome before, during and post COVID-19 pandemic: English sentinel network cohort studies
Sneha N Anand
Favorite
Ancona, Domenica

Centro Regionale Farmacovigilanza Regione Puglia
(120) How much frequently are biological drugs used in patients over 65 years with immune-mediated inflammatory diseases through the Italian VALORE distributed database network
Domenica Ancona
Favorite
(CSPOT24) Trajectories of adherence to biological drugs in patients with inflammatory bowel diseases: the VALORE project
Domenica Ancona
Favorite
Andaur Navarro, Constanza L.

Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
(154) Fit-for-purpose evaluation of Real-World Data for vaccines and medicines safety studies: the INSIGHT tool
Constanza L. Andaur Navarro
Favorite
(349) Patient-level prognostic models for COVID-19 vaccine effectiveness and safety: a systematic review
Constanza L. Andaur Navarro
Favorite
Andersen, Ina

Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
(054) Initiation of SGLT2i vs GLP1-RA and the Risk of Acute Kidney Injury in Persons with Type 2 Diabetes Mellitus
Ina Andersen
Favorite
(225) Peyronie´s disease and risk of depression. A nationwide 25-year cohort study
Ina Andersen
Favorite
Andersen, Kathleen

Johns Hopkins Bloomberg School of Public Health
(099) Distinguishing Hospital Encounters as "with" vs "for" COVID-19 Using A Large US Administrative Claims Database
Kathleen Andersen
Favorite
(105) Hospital-level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort Study
Kathleen Andersen
Favorite
(365) Tokenization and linkage of state vaccine registry data to improve determination of COVID-19 vaccination status in a large administrative claims database
Kathleen Andersen
Favorite
Andersen, Per Normann

Inland Norway University of Applied Sciences
(244) Psychotropic drug use among 0-17 year old Norwegians during 2014-2021: a nationwide register study
Per Normann Andersen
Favorite
Anderson, Josie

Harvard Pilgrim Health Care Institute
(305) Prevalence of Selected Health Conditions among Individuals with Childbearing Potential to Inform the Development of the Pregnancy Safety Study Framework
Josie Anderson
Favorite
Anderson, Steven

Food and Drug Administration
(258) Evaluation of the Vaccinated Concurrent Comparator Methodology for Near Real Time Safety Surveillance
Steven Anderson
Favorite
(275) Linkage of Mother and Infant Records using Commercial Claims Data within the Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative
Steven Anderson
Favorite
(352) Safety of Ancestral Monovalent BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax) COVID-19 Vaccines in US Children Aged 6 months to 17 years
Steven Anderson
Favorite
(358) Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 months and Older in the United States
Steven Anderson
Favorite
(362) Stroke Risk Following Receipt of High-Dose/Adjuvanted Influenza Vaccinations Among U.S. Adults Aged ≥65 Years; 2016-2019
Steven Anderson
Favorite
Anderssen-Nordahl, Emilie

Vall Hebron
(131) Pharmacological treatments and medication-related problems in nursing homes in Catalonia: The impact of a multidisciplinary team intervention
Emilie Anderssen-Nordahl
Favorite
Andersson, Marine

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
(189) Risk identification based on prescribed drugs and comorbidities in patients with Torsade de pointes arrhythmia – a population-based Swedish cohort study.
Marine Andersson
Favorite
Andersson, Therese

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden
(186) Flexible parametric survival models for simultaneous estimation on multiple timescales: an application using nationwide Swedish register data
Therese Andersson
Favorite
Andonova, Desislava

Faculty of Pharmacy, Medical University of Plovdiv
(007) Comparative Analysis of Medicines Under Additional Monitoring in the European Union and Bulgaria
Desislava Andonova
Favorite
(245) Benefit-Risk Assessment of Herbal Medicines Used During Pregnancy and Lactation: A Descriptive Study of Registered Herbal Medicines in Bulgaria
Desislava Andonova
Favorite
Ando, Takayuki

Keio University
(166) A Novel, Hypothesis-free Approach to Detecting Safety Signals by Clustering Distributed Representations of Adverse Events Based on Claims Databases
Takayuki Ando
Favorite
Andrade, Susan

Harvard Pilgrim Health Care Institute
(233) Algorithms to identify major congenital malformations in routinely collected healthcare databases: A systematic literature review
Susan Andrade
Favorite
(316) The IMEDS Distributed Database Network and Pregnancy Studies
Susan Andrade
Favorite
Andresen, Kirsty

London School of Hygiene and Tropical Medicine
(195) Optimal matching ratios for the analysis of time-to-event outcomes in matched cohort studies in EHR research: A simulation study
Kirsty Andresen
Favorite
Angelici, Laura

Department of Epidemiology, ASL Roma1, SSR Lazio, Rome, Italy
(121) Mortality associated with use of etelcalcetide versus cinacalcet for the treatment of secondary hyperparathyroidism in patients in haemodialysis: a population based study in Lazio, Italy
Laura Angelici
Favorite
Angell, Jonathan

University of Toronto
(271) Improving Access to HIV-Related Healthcare, including Treatment and Pre-Exposure Prophylaxis (PrEP) in Zimbabwe Among Young Mothers Living with HIV
Jonathan Angell
Favorite
Anggadiredja, Kusnandar

School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Institut Teknologi Bandung (ITB), Bandung, Indonesia
(291) Interest in Use of a Mobile App for Reporting Adverse Drug Reactions: A Survey Study Among Healthcare Professionals and the Public in Indonesia
Kusnandar Anggadiredja
Favorite
Angleman, Sara

PPD, Part of Thermo Fisher Scientific
(CSPOT44) Planned and Ongoing EMA-mandated Post-approval Observational Studies of Cell & Gene Therapies (CGT): What Can We Learn from Study Characteristics?
Sara Angleman
Favorite
An, Huijun

Johns Hopkins Bloomberg School of Public Health
(105) Hospital-level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States: A Retrospective Cohort Study
Huijun An
Favorite
Anito, Abenezer

Ohio State Global One Health
(331) Applicability of Selected Brighton Collaboration Case Definitions in Prospective Hospital-Based Safety Surveillance for Covid-19 Vaccines, Addis Ababa, Ethiopia
Abenezer Anito
Favorite
An, Jaejin

Kaiser Permanente Southern California
(096) GLP1 comparative effectiveness against dementia onset in a large, multi-site cohort of type 2 diabetes patients: a trial emulation approach with targeted learning
Jaejin An
Favorite
Ankrah, Daniel

Korle Bu Teaching Hospital
(181) Medication adherence and its association with blood pressure control at a teaching hospital in Ghana
Daniel Ankrah
Favorite
An, Linna

First Affiliated Hospital of XinJiang Medical University
(245) Comparative Effectiveness of Single-Drug Versus Vancomycin-based Combination Antimicrobial Regimens in Post-Neurosurgical Infections at a Northwest China Hospital
Linna An
Favorite
Anna Theresa Weber, Silke

Botucatu Medical School (FMB) of São Paulo State University (Unesp), Botucatu, São Paulo, Brazil
(298) Are Costs Decisive in the Incorporation of Medicines for the Treatment of Ultra-rare Diseases in Brazil? Trends in Healthcare Coverage for Ultra-rare Diseases
Silke Anna Theresa Weber
Favorite
(BSPOT36) Assessing Clinical Evidence for the Incorporation of Technologies in Ultra-rare Diseases in Brazil: A Decade of CONITEC Reports
Silke Anna Theresa Weber
Favorite
Annan, Augustine

Korle Bu Teaching Hospital
(181) Medication adherence and its association with blood pressure control at a teaching hospital in Ghana
Augustine Annan
Favorite
Ansah, Gabriel

Artificial Intelligence , Vrije University Amsterdam
(062) Identifying Adverse Drug Reactions Through Knowledge Graph Modeling
Gabriel Ansah
Favorite
Anteyi, Kate

Moderna, Inc.
(102) Evaluation of postmenopausal hemorrhage following Moderna COVID-19 vaccines: results from surveillance data analysis and interim results from a US claims database cohort study
Kate Anteyi
Favorite
Antoniou, Tony

Li Ka Shing Knowledge Institute, St. Michael’s Hospital
(ASPOT20) Population-level utilization of direct-acting antiviral agents and trends in hepatitis C related hospitalizations
Tony Antoniou
Favorite
Antoon, James

Vanderbilt University Medical Center
(228) Beta-blocker-associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database
James Antoon
Favorite
(246) Comparative Postmarketing Safety Assessment of Baloxavir Marboxil vs Oseltamivir using TreeScan™
James Antoon
Favorite
Antunes, Ana

Real World Solutions, IQVIA
(344) Effectiveness Of Pertussis Vaccines In Children Between 2013 And 2019 In France: A Nested Matched Case Control Study Using The National Health Data System
Ana Antunes
Favorite
Antunes, Luis

IQVIA (Portugal)
(169) Application of the Target Trial Emulation Framework to External Comparator Studies
Luis Antunes
Favorite
Anveden-Berglind, Ina

Karolinska Institutet
(CSPOT21) The Risk of Venous Thromboembolism in Two of the Most Common Inflammatory Skin Diseases - a Comparative Cohort Study Consisting of the Adult Populations of Atopic Dermatitis and Psoriasis in the Swedish Specialist Care
Ina Anveden-Berglind
Favorite
Apata, Jummai

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U. S. Food and Drug Administration
(141) Assessing Exposure to Recently Approved Medications to Inform Feasibility for Signal Identification Analyses in the FDA’s Sentinel System
Jummai Apata
Favorite
Aptekar, Jacob

Medidata AI, Medidata, a Dassault Systèmes company
(074) Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in Advanced Non-Small Cell Lung Cancer (aNSCLC): Analysis of Patient-Level Pooled Randomized Clinical Trials (RCTs)
Jacob Aptekar
Favorite
Arafah, Amal

Pharmacovigilance Executive Directorate (Pharmacovigilance Inspection Section), Saudi Food and Drug Authority, Riyadh, Saudi Arabia
(010) Comprehensive Analysis of Pharmacovigilance Inspections Practices: Focus on QPPV Responsibilities in the Pharmaceutical Industry in Saudi Arabia
Amal Arafah
Favorite
Aragão, Erika

Federal University of Bahia
(057) Spatial-Temporal Patterns In Biologic Prescriptions For Inflammatory Bowel Diseases In The Public Healthcare System In Brazil
Erika Aragão
Favorite
Arai, Hidenori

Department of Epidemiology of Aging, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan
(137) Risk of sarcopenia following long-term statin use in community-dwelling middle-aged and older adults in Japan: evidence from a 10-year population-based cohort study using propensity score matching and overlap weighting
Hidenori Arai
Favorite
Arakaki, Brent

Aetion, Inc.
(102) Evaluation of postmenopausal hemorrhage following Moderna COVID-19 vaccines: results from surveillance data analysis and interim results from a US claims database cohort study
Brent Arakaki
Favorite
(129) Safety of Moderna’s mRNA-1273.222 bivalent omicron-containing vaccine: interim results from a US claims database cohort study
Brent Arakaki
Favorite
Araki, Masako

Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.
(ASPOT24) Cardiovascular Medicine Use in Adults with ADHD: A Nationwide Study in Australia
Masako Araki
Favorite
Arana, Alejandro

RTI Health Solutions
(344) Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Alejandro Arana
Favorite
Araujo, Andre

Moderna Inc.
(341) Early use of Moderna’s mRNA-1273.815 monovalent vaccine: a descriptive analysis of a US Claims database
Andre Araujo
Favorite
Araujo, Jhajaira

Centro de Investigación Básica y Traslacional, Auna Ideas, Lima, Peru
(060) Genomic profiling and the need for immunotherapy in gastric cancer
Jhajaira Araujo
Favorite
araujo, Lita

Sanofi
(004) Clinical and Economic Burden of Polymyalgia Rheumatica in Patients with an Inadequate Response to Glucocorticoids or Glucocorticoids Taper in a Real-World Setting
Lita araujo
Favorite
(149) Characteristics Associated with Long-Term Glucocorticoid Use in Patients with New Onset Polymyalgia Rheumatica
Lita araujo
Favorite
Archambault, Alexi N.

Regeneron
(063) Identifying the Period of Heightened Risk for Adrenal Insufficiency in Patients with Advanced Non-Small Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
Alexi N. Archambault
Favorite
(065) Incidence of any Infections and SARS-COV-2 infections in Patients Receiving Treatment for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Real-World Evidence from a Large US National Claims Database
Alexi N. Archambault
Favorite
Ardavani, Ashkon

University of Leicester
(118) Ethnicity and polypharmacy in people with chronic kidney disease: a pharmacoepidemiologic perspective
Ashkon Ardavani
Favorite
Ardoino, Ilaria

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan
(123) Improving Prescription Appropriateness of Proton Pump Inhibitors: The LAPTOP-PPI Study
Ilaria Ardoino
Favorite
(284) Attitudes and barriers to deprescribing in general practice: the perspective of general practitioners.
Ilaria Ardoino
Favorite
Arena, Patrick

Aetion, Inc.
(007) Beyond external control arms: utility of real-world data in oncology regulatory applications
Patrick Arena
Favorite
(017) Forging a Path for Transporting Real-World Evidence: Existing Applications & Proposed Practices
Patrick Arena
Favorite
Arinze, Johnmary

Department of Medical Informatics, Erasmus Medical Center
(161) DARWIN EU® - Real-World Evaluation of Pulmonary Arterial Hypertension Treatment and Outcomes in Europe
Johnmary Arinze
Favorite
(247) DARWIN EU® - Characterization of Patients with Chronic Hepatitis B and C
Johnmary Arinze
Favorite
(321) DARWIN EU® - Background Rates of Outcomes of Interest in Patients with Severe Asthma
Johnmary Arinze
Favorite
Ariti, Cono

OXON Epidemiology, Madrid, Spain
(024) Mortality in an Eosinophilic Granulomatosis with Polyangiitis (EGPA) Incident Cohort: A Retrospective Study in England
Cono Ariti
Favorite
armitage, Christopher

2. Manchester Centre for Health Psychology, Division of Psychology and Mental Health, University of Manchester, Manchester, UK
(223) Risk of post-surgical persistent opioid use and fractures in patients undergoing major surgery in England
Christopher armitage
Favorite
Armoiry, Xavier

UMR CNRS 5510 MATEIS, Pharmacy Department, Hôpital Édouard-Herriot, Institut des Sciences Pharmaceutiques et Biologiques (ISPB), Université Claude Bernard Lyon 1, 69008 Lyon, France
(152) Determinants of Use of Minimally Invasive Robot-Assisted Surgery: a Cohort Study from the French Nationwide Claims Database
Xavier Armoiry
Favorite
(BSPOT15) Transcatheter and Surgical Aortic Valve Implantation in the Management of Aortic Stenosis between 2010 and 2022: a French Nationwide Study
Xavier Armoiry
Favorite
Armstrong, Róisín

Rallybio
(264) Fetal and Neonatal Alloimmune Thrombocytopenia: Systematic Literature Review and Challenges Encountered
Róisín Armstrong
Favorite
Arnaud, Mickael

Real World Solutions, IQVIA
(344) Effectiveness Of Pertussis Vaccines In Children Between 2013 And 2019 In France: A Nested Matched Case Control Study Using The National Health Data System
Mickael Arnaud
Favorite
Arnold, Kellyn

IQVIA (London)
(169) Application of the Target Trial Emulation Framework to External Comparator Studies
Kellyn Arnold
Favorite
Arora, Tarun

FASTER Medicine
(095) COVID-19 Lockdown and the Osteoporosis Treatment Among US Medicare Enrollees Who Initiated Romosozumab
Tarun Arora
Favorite
(134) The Impact of COVID-19 Containment Strictness on the Administration of Romosozumab among Medicare Enrollees in the Most Socioeconomically Vulnerable Counties in the US
Tarun Arora
Favorite
(CSPOT46) Comparative Effectiveness of Denosumab versus Bisphosphonates among Treatment-Experienced Postmenopausal Women with Osteoporosis in the U.S. Medicare Program
Tarun Arora
Favorite
(CSPOT49) Comparative Effectiveness of Denosumab versus Zoledronic Acid among Postmenopausal Women with Osteoporosis in the U.S. Medicare Program
Tarun Arora
Favorite
Artignan, Audrey

Costello Medical
(307) Replicating a Published Real-World Evidence Study to Analyze Maternal Delivery Complications Using Electronic Medical Records from Community Hospitals
Audrey Artignan
Favorite
Arzenton, Elena

Department of Diagnostics and Public Health, Pharmacology Unit, University of Verona, Verona, Italy
(037) Switching proportion assessment in rheumatoid arthritis patients exposed to disease modifying anti-rheumatic drugs: systematic review and meta-analysis
Elena Arzenton
Favorite
Asao, Keiko

IQVIA Solutions Japan G.K.
(033) Review of Pharmacovigilance Practice of Biosimilars in Japan
Keiko Asao
Favorite
Aseafan, Mohamed

Department of Medicine, Security Forces Hospital, Riyadh
(016) Empirical Estimation of Hepatocellular Carcinoma Prevalence in Saudi Arabia: A Gender and Age Group Analysis
Mohamed Aseafan
Favorite
Asgarisabet, Parisa

Cardinal Health
(001) A Novel Methodology for Assessing Response to Lymphoma Treatment using Real World Data – the Real-World Lugano (rwLugano) Study
Parisa Asgarisabet
Favorite
(013) Clinical Features Associated with Disease Response Classification in Lymphoma: A Comparison of Data from Manual Chart Review and Blinded Independent Central Review
Parisa Asgarisabet
Favorite
(017) Feasibility of Using Deidentified Positron Emission Tomography–Computed Tomography (PET-CT) Scans to Support a Blinded Independent Central Review for Lymphoma Treatment Response Assessment using Real-World Data
Parisa Asgarisabet
Favorite
Ashcroft, Darren

Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester
(112) Investigating Previous Antibiotic Exposure Patterns among COVID-19 Hospitalised Patients: An OpenSAFELY Matched Case-Control Study
Darren Ashcroft
Favorite
(222) Prevalence and variations of potential hazardous opioid prescribing across the United Kingdom general practices
Darren Ashcroft
Favorite
(223) Risk of post-surgical persistent opioid use and fractures in patients undergoing major surgery in England
Darren Ashcroft
Favorite
Ashcroft, Quinta

Lancashire Teaching Hospitals NHS Foundation Trust
(124) Incidence and Complications of Rectopexy in the United Kingdom and United States, 2013-2022.
Quinta Ashcroft
Favorite
(297) Use of systemic fluoroquinolones in primary care and hospital settings in the UK: A population-level cohort study
Quinta Ashcroft
Favorite
Ashram, Waddah

Department of medicine, Faculty of Medicine, King Abdulaziz University
(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia
Waddah Ashram
Favorite
Asiimwe, Alex

Gilead Sciences
(161) Linking clinical trial participants to their U.S. real-world data through tokenization: a practical guide
Alex Asiimwe
Favorite
(169) Quantification of information gained by linking claims data to an EHR cohort of US metastatic breast cancer (mBC) patients
Alex Asiimwe
Favorite
Asiri, Amal

PharmacoTherapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands
(049) Hypoglycaemia Risk and Medication De-intensification in Diabetes Patients: A Cohort Study
Amal Asiri
Favorite
Askar, Mohsen Gamal Saad

The artic university of Norway
(125) Low-Dose Aspirin and Risk of Anemia in Older Adults: Insights from a Danish Register-based Study
Mohsen Gamal Saad Askar
Favorite
Askin, Gulce

AETION Inc.
(075) Real-World Treatment of Patients with Chronic Lymphocytic Leukemia: Results from Analysis of US Health Insurance Claims Dataset
Gulce Askin
Favorite
Asmus, Michael

Sanofi
(323) High Systemic Corticosteroid Burden Among Patients with Uncontrolled Moderate-to-severe Asthma in the US
Michael Asmus
Favorite
Asomaning, Kofi

Pfizer, Inc., New York, NY, USA
(260) Evaluation of Digital Data collection Methods in a Prospective Pregnancy Registry for a Migraine Product with Both Acute and Preventive Indications
Kofi Asomaning
Favorite
(273) Gabapentin in Pregnancy and Birth Outcomes: a Population-based Prevalence Study in Nordic Countries (EUPAS38620)
Kofi Asomaning
Favorite
(342) Final Results from Post-Emergency Use Authorization (EUA) Active Safety Surveillance Study among Individuals in the Veterans Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine
Kofi Asomaning
Favorite
Asrar, Mir Mahmood

CSIR-Indian Institute of Integrative Medicine
(225) Unveiling the Impact of Spironolactone in Women with PCOS: Beyond Its Anti-androgen Properties - Insights from a Systematic Review and Meta-analysis
Mir Mahmood Asrar
Favorite
Assefa, Brhane

Mekelle University
(227) Assessment of Age-appropriateness and Acceptability of Oral Medicine Formulations for Children Less than 5 Years in a Low Income Setting
Brhane Assefa
Favorite
Asselbergs, Folkert

Amsterdam UMC
(146) An Electronic Health Record Analysis Studying Differences in Medication Use Associated with Renal Impairment in Acute Heart Failure
Folkert Asselbergs
Favorite
Assi, Nada

Heva, Epidemiology Department, Lyon, France
(355) Relative effectiveness (rVE) of the high-dose vs. standard-dose influenza vaccines in the French National health data system (SNDS) for people aged 65+ living in community, obtained using two approaches based on the propensity score
Nada Assi
Favorite
Asubonteng, Julius

Regeneron
(063) Identifying the Period of Heightened Risk for Adrenal Insufficiency in Patients with Advanced Non-Small Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors
Julius Asubonteng
Favorite
(065) Incidence of any Infections and SARS-COV-2 infections in Patients Receiving Treatment for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Real-World Evidence from a Large US National Claims Database
Julius Asubonteng
Favorite
(132) A Framework for Rapid Analysis of Real-World Data in Safety Signal Assessment
Julius Asubonteng
Favorite
(172) Feasibility Assessment of Hypertension among Patients with Diabetic Macular Edema using Real World Data
Julius Asubonteng
Favorite
(299) Assessing the agreement between open and closed medical claims in a rare disease cohort
Julius Asubonteng
Favorite
(BSPOT38) Estimating period prevalence: comparing methods to describe a rare disease population
Julius Asubonteng
Favorite
Athavil, Krishnakumar

Department of Pharmacy Practice,Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education
(233) Development of a multivariate prognostic model to predict mortality in neonatal sepsis patients.
Krishnakumar Athavil
Favorite
Atkinson, Andrew

Washington University School of Medicine
(171) Quantifying the impact of different look-back period criteria to identify new users when medication adherence is poor: A study of chronic medications for opioid use disorder
Andrew Atkinson
Favorite
Atkinson, Jheanelle

Meharry Medical College
(BSPOT20) Prevalence and treatment of chronic hypertension during pregnancy in a U.S. cohort, 2008-2021
Jheanelle Atkinson
Favorite
Attinson, Dionna

AETION Inc.
(075) Real-World Treatment of Patients with Chronic Lymphocytic Leukemia: Results from Analysis of US Health Insurance Claims Dataset
Dionna Attinson
Favorite
Atzinger, Christopher

Astellas
(ASPOT02) Contents of a Strong Real World Data Quality and Relevance Package for Regulatory or Health Technology Assessment Submission
Christopher Atzinger
Favorite
Aubrun, Elodie

Novartis Pharma AG, Basel, Switzerland
(294) Pregnancies and prescription drug use during pregnancy in women of childbearing potential with chronic spontaneous urticaria in the United States – A descriptive analysis
Elodie Aubrun
Favorite
(BSPOT03) Advancing Health Equity in Europe: A Framework of Diversity and Fairness in Pharmacoepidemiologic Research
Elodie Aubrun
Favorite
Aucott, John

Johns Hopkins School of Medicine
(254) Enhancing US Lyme Disease Detection in Claims Data: Identifying Acute and Disseminated Disease
John Aucott
Favorite
Audigier-Valette, Clarisse

Pneumology Department, Centre Hospitalier Sainte Musse, Toulon, France
(011) Characteristics and treatment sequences of patients with KRAS G12C, other KRAS and KRAS-wild-type advanced or metastatic (AM) Non-Small Cell Lung Cancer (NSCLC) in the French ESME cohort
Clarisse Audigier-Valette
Favorite
Aurelius, Taylor

Drug Safety Research Unit (DSRU)
(367) VAC4EU study to identify risk factors and characterize the clinical course of myocarditis/pericarditis following mRNA-1273 vaccination in four European countries: first descriptive analyses
Taylor Aurelius
Favorite
Austin, Amy

Truveta
(094) Concomitant prescribing of nirmatrelvir/ritonavir (NMV-r) and medications with potential risk for drug-drug interaction – a feasibility assessment of Truveta Electronic Health Records Database.
Amy Austin
Favorite
Austin, Peter

Institute for Clinical Evaluative Sciences
(170) Minimizing Confounding in Comparative Observational Studies with Time-To-Event Outcomes: An Extensive Comparison of Covariate Balancing Methods Using Monte Carlo Simulation
Peter Austin
Favorite
Avalos, Lyndsay

Division of Research, Kaiser Permanente Northern California
(262) Antidepressant and Psychotherapy Initiation Among Patients with New Episodes of Depression During Pregnancy
Lyndsay Avalos
Favorite
Avery, Antony

School of Medicine, University of Nottingham, Nottingham
(222) Prevalence and variations of potential hazardous opioid prescribing across the United Kingdom general practices
Antony Avery
Favorite
Avila-Tang, Erika

FDA
(BSPOT08) Enhancing Early Detection of Medical Device Safety Signals: A Case Study of Implantable Cardioverter Defibrillator Leads
Erika Avila-Tang
Favorite
Avorn, Jerry

Brigham and Women's Hospital
(287) EHR-based pragmatic trial evaluating the impact of simulation intervention on high-risk prescribing to older adults by junior physicians
Jerry Avorn
Favorite
(318) Comparative effectiveness and safety of single-inhaler triple therapy for COPD
Jerry Avorn
Favorite
Avula, Ramya

Carelon
(275) Linkage of Mother and Infant Records using Commercial Claims Data within the Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative
Ramya Avula
Favorite
Awoke, Tadesse

University of Gondar, Ethiopia
(341) Evaluating impact of time-varying confounders in self-controlled risk interval analysis in a vaccine-safety cohort event monitoring-based simulation study
Tadesse Awoke
Favorite
Aydin, Volkan

Department of Medical Pharmacology, International School of Medicine, Istanbul Medipol University
(045) Effect of COVID-19 restrictions on insulin consumption in Turkey: Results from Changes in Nationwide Drug Consumption During the Pandemic Study
Volkan Aydin
Favorite
(113) Investigation of the Consumption Trend of Inhalants Used in the Treatment of Obstructive Airway Diseases During the COVID-19 Pandemic
Volkan Aydin
Favorite
Azevêdo, Ana Regina

Federal University of Minas Gerais
(288) Self-test as a strategy to promote HIV testing among men who have sex with men and transgender women - overview of systematic reviews and meta-analyses
Ana Regina Azevêdo
Favorite
Aziz, Ziad

University of Groningen
(262) Frequency and Duration of Antibiotic Shortages: A Global Comparison
Ziad Aziz
Favorite
Aznar-Lou, Ignacio

Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research Group, Teaching, Research & Innovation Unit, Parc Sanitari Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Santa Rosa 39-57, 08950, Esplugues de Llobregat, Spain.
(312) Identifying Longitudinal Medication Adherence Patterns of Antipsychotic Treatments; A Real-World Cohort Study in Catalonia, Spain.
Ignacio Aznar-Lou
Favorite
Azoulay, Laurent

McGill University
(052) Incretin-Based Drugs and the Incidence of Endometrial Cancer Among Patients with Type 2 Diabetes
Laurent Azoulay
Favorite
(BSPOT25) Proton Pump Inhibitors Use and Risk of Inflammatory Bowel Disease in Children: A Population-based Cohort Study
Laurent Azoulay
Favorite
Azzi, Jessica

Servier
(311) Generalized anxiety disorder: Epidemiology, burden, and comorbid depression.
Jessica Azzi
Favorite
Azzouz, Brahim

Reims University Hospitals
(305) Daridorexant and sleeping disorders: comparative study with sleeping medication (zopiclone, oxazepam).
Brahim Azzouz
Favorite